Researchers found that fewer dupilumab-receiving patients had high mucus plug scores at week 24 than at baseline (32.8 vs 67.2%). HealthDay News — Dupilumab reduces mucus plug scores and improves lung ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...

Please provide your email address to receive an email when new articles are posted on . Reductions in mucus plug scores correlated with reductions in fractional exhaled nitric oxide levels. These ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

WASHINGTON -- Dupilumab (Dupixent) reduced airway inflammation and increased lung capacity in patients with uncontrolled, moderate-to-severe asthma, while also reducing troublesome mucus plugs, a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Dupilumab for uncontrolled asthma improved mucus ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD) patients AER-01-002 is well powered to determine if 28-days ...

After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12-week study enrolling up to 20 CF ...

As a cold ends, a severe mucus cough starts. Sound familiar? Two studies now give explanations: First, crucial mechanisms of the mucus in both diseased and healthy airways; second, what happens in ...